4.8 Article

Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands

Journal

NATURE BIOTECHNOLOGY
Volume 39, Issue 10, Pages 1220-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41587-021-00900-z

Keywords

-

Funding

  1. Lustgarten Foundation for Pancreatic Cancer Research
  2. Marcus Foundation
  3. Virginia and D.K. Ludwig Fund for Cancer Research
  4. Conrad N. Hilton Foundation
  5. John Templeton Foundation
  6. Medical Research Future Fund Investigator Grant [APP1194970]
  7. National Institutes of Health [T32 GM007309, U01 CA230691-01, P50 CA228991, U01 CA200469, R37 CA230400-01, U01 CA152753]

Ask authors/readers for more resources

The SaferSeqS method efficiently detects low-frequency mutations by introducing identical molecular barcodes and enriching target sequences with strand-specific PCR, achieving high sensitivity and specificity, and detecting variants at frequencies below 1 in 100,000 DNA template molecules with a background mutation rate of <5 x 10(-7) mutants per base pair (bp).
Mutations present at a low frequency in a sample are detected with high sensitivity and a low error rate. Identification and quantification of low-frequency mutations remain challenging despite improvements in the baseline error rate of next-generation sequencing technologies. Here, we describe a method, termed SaferSeqS, that addresses these challenges by (1) efficiently introducing identical molecular barcodes in the Watson and Crick strands of template molecules and (2) enriching target sequences with strand-specific PCR. The method achieves high sensitivity and specificity and detects variants at frequencies below 1 in 100,000 DNA template molecules with a background mutation rate of <5 x 10(-7) mutants per base pair (bp). We demonstrate that it can evaluate mutations in a single amplicon or simultaneously in multiple amplicons, assess limited quantities of cell-free DNA with high recovery of both strands and reduce the error rate of existing PCR-based molecular barcoding approaches by >100-fold.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available